Search filters

List of works by Suresh S Ramalingam

A new standard of care for patients with surgically unresectable stage III non-small cell lung cancer

scientific article published on 02 March 2019

Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials

scientific article published on 24 October 2019

Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature

scientific article published on 28 September 2017

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

article

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base

scientific article

ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib

scientific article published on 10 December 2019

Efficacy and safety of immune checkpoint blockade in self-identified black patients with advanced non-small cell lung cancer

scientific article published on 09 September 2020

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer

scientific article published on 26 November 2019

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.

scientific article

Health care disparities among octogenarians and nonagenarians with stage III lung cancer

scientific article published on 8 January 2018

Immune checkpoint inhibitors in advanced non-small cell lung cancer

scientific article published on 6 December 2017

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.

scientific article

MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor-mutant lung cancers

scientific article published on 04 June 2020

Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.

scientific article

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies

scientific article published on 04 December 2018

Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

scientific article published on 30 January 2020

Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q

scientific article published on 21 April 2020

Scientific Advances in Lung Cancer 2015.

scientific article published on 21 March 2016

Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy

scientific article published on 18 August 2018

Targeting KRAS-Mutant Non-Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations

scientific article published on 26 October 2020

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy

scientific article published on 17 October 2018

Paulina is supported by:

About Paulina

Help